Related Experiment Video
Updated: Jun 10, 2026
10:33
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
Published on: September 4, 2017
Evaluations of Dose-effect Curves and Half-maximal Effective Doses Using the Four-parameter Logistic Model: When are
Tianran Yu1, Xinya Li2, Tinghe Yu2
1College of Pharmaceutical Sciences, Southwest University, Chongqing, China.
Current Neuropharmacology
|June 9, 2026
Summary
The four-parameter logistic model calculates nominal ED50, which may differ from the real ED50, leading to trial inconsistencies. Understanding the model
Area of Science:
- Pharmacology
- Biostatistics
- Toxicology
Background:
- The four-parameter logistic (4PL) model is standard for dose-response curve analysis, particularly for determining the half-maximal effective dose (ED50).
- Misinterpretation of ED50 derived from the 4PL model is a common issue in scientific literature and drug development.
- Accurate ED50 determination is critical for assessing drug efficacy and safety.
Purpose of the Study:
- To investigate the discrepancies between the nominal ED50 calculated by the 4PL model and the actual (real) ED50.
- To identify conditions under which the 4PL model's ED50 deviates from the true ED50.
- To highlight the implications of these deviations for interpreting experimental results and clinical trials.
Main Methods:
- Calculated ED50 values using the standard 4PL model under various simulated conditions.
- Compared the calculated nominal ED50 with the true ED50 for each condition.
- Analyzed the relationship between the model parameters (top and bottom plateaus) and the accuracy of the nominal ED50.
Main Results:
- The ED50 derived from the 4PL model is a nominal value, representing the dose at 50% of the (top+bottom) range, not necessarily 50% of the full range.
- Nominal ED50 equals, underestimates, or overestimates the real ED50 when (top+bottom)/2 is 0.5, <0.5, or >0.5, respectively.
- The real ED50 cannot be determined when the dose-response curve does not span the full range of death rates (0 to 1).
Conclusions:
- The nominal ED50 can lead to overestimation or underestimation of drug effects, potentially causing inconsistencies in trial outcomes.
- Errors often arise from neglecting the 4PL model's assumptions, specifically that the minimal death rate is 0 and the maximal death rate is 1.
- Accurate ED50 determination requires considering the entire dose-response curve, especially when comparing multiple curves or in drug combinations.
Related Concept Videos
01:21Dose Response Curve: Conventional Versus Nonmonotonic
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
01:28Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly proportional to...
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
01:15Pharmacodynamic Models: Logarithmic Concentration–Effect Model
The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration, limiting its...
01:23Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship
Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates that even as drug...